市場調査レポート
商品コード
1252920

動物用寄生虫駆除剤の世界市場:種類別 (外部寄生虫駆除剤、内部寄生虫駆除剤、エンデクトサイド)・動物の種類別 (犬、猫、馬、牛、豚、家禽、山羊)・エンドユーザー別 (動物病院、動物農場、在宅医療) の将来予測 (2027年まで)

Animal Parasiticides Market by Type (Ectoparasiticides, Endoparasiticides, Endectocides), Animal Type (Dogs, Cats, Horses, Cattle, Pigs, Poultry, Goats), End User (Veterinary Hospitals, Animal farms, Home Care Settings) - Global Forecast to 2027

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 285 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
動物用寄生虫駆除剤の世界市場:種類別 (外部寄生虫駆除剤、内部寄生虫駆除剤、エンデクトサイド)・動物の種類別 (犬、猫、馬、牛、豚、家禽、山羊)・エンドユーザー別 (動物病院、動物農場、在宅医療) の将来予測 (2027年まで)
出版日: 2023年03月28日
発行: MarketsandMarkets
ページ情報: 英文 285 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の動物用寄生虫駆除剤の市場規模は、2022年の106億米ドルから2027年には141億米ドルに達し、予測期間中に5.8%のCAGRで成長する、と予測されています。

動物寄生虫駆除剤の市場は、動物由来食品の需要増加や、民間企業の投資拡大、動物の疾病蔓延防止を目的とした法律、動物医療にかかる費用の上昇といったの要因によって拡大しています。他方、食品生産用動物に対する寄生虫駆除剤の使用に関する規制や菜食主義への移行が、この市場の成長を妨げると思われます。

"種類別では、外部寄生虫駆除剤分野が最も高いシェアを占めている"

種類別に見ると。2021年には外部寄生虫駆除剤の部門が最も高いシェアを占めています。他の製品に比べて外部寄生虫駆除剤の普及率が高いことや、動物の所有権の上昇、新興国におけるコンパニオンアニマルの増加などが、今後の市場拡大を促進する主な要因として挙げられます。

"予測期間中、コンパニオンアニマル分野が最も高い市場シェアを占める"

動物の種類別に見ると、2021年にはコンパニオンアニマルが最大のシェアを占めています。その主な理由として、ペットの飼育コストの上昇と、先進国におけるコンパニオンアニマルの飼育者数の増加などが挙げられます。

"動物病院・クリニック分野は、予測期間中に最も速い成長を遂げる"

エンドユーザー別に見ると、2021年には動物病院・クリニックの分野が最も急速に成長しています。医療現場での動物用寄生虫駆除剤の使用の増加、寄生虫病の増加、発展途上国における動物の健康に対する関心の高まりなどが、この分野の急成長の要因となっています。

"予測期間中、ラテンアメリカが最も速い成長を遂げる"

地域別に見ると、ラテンアメリカが予測期間中に急速な成長を遂げると思われます。コンパニオンアニマルや食用動物の数の増加、および動物由来食品に対するこの地域の需要の高まりが、市場成長を促す主な要因となっています。特に、中南米諸国からの牛肉輸出の増加が、この地域の動物用寄生虫駆除剤の市場拡大をサポートすると予想されます。

当レポートでは、世界の動物用寄生虫駆除剤の市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、種類別・動物の種類別・エンドユーザー別・地域別の市場動向の見通し、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 価格分析
  • サプライチェーン分析
  • エコシステム分析
  • 特許分析
  • バリューチェーン分析
  • ケーススタディ
  • 規制分析
  • ポーターのファイブフォース分析
  • 隣接市場分析
  • 主な会議とイベント (2023年~2024年)
  • 主な利害関係者と購入基準
  • 貿易分析
  • 業界動向
  • 動物用寄生虫駆除剤市場に対するインフレと景気後退の影響

第6章 動物用寄生虫駆除剤市場:種類別

  • イントロダクション
  • 外部寄生虫駆除剤
    • ポアオン剤・スポットオン剤
    • 経口錠剤
    • スプレー剤
    • ディップ剤
    • 耳タグ
    • 首輪
    • その他の外部寄生虫駆除剤
  • 内部寄生虫駆除剤
    • 経口液剤
    • 経口固形剤
    • 注射剤
    • 飼料添加物
    • その他の内部寄生虫駆除剤
  • エンデクトサイド

第7章 動物用寄生虫駆除剤市場:動物の種類別

  • イントロダクション
  • コンパニオンアニマル
    • その他のコンパニオンアニマル
  • 家畜
    • 家禽
    • 羊・山羊
    • その他の家畜

第8章 動物用寄生虫駆除剤市場:エンドユーザー別

  • イントロダクション
  • 動物病院・クリニック
  • 動物農場
  • 在宅医療

第9章 動物用寄生虫駆除剤市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • 他の欧州諸国
  • アジア太平洋
    • 中国
    • オーストラリア・ニュージーランド
    • 日本
    • インド
    • 韓国
    • 他のアジア太平洋諸国
  • ラテンアメリカ
    • ブラジル
    • 他のラテンアメリカ諸国
  • 中東・アフリカ
    • トルコ
    • 他の中東・アフリカ諸国

第10章 競合情勢

  • 概要
  • 主要企業の戦略
  • 動物用寄生虫駆除剤市場:主要企業の収益シェア分析
  • 市場シェア分析
  • 主要企業の研究開発 (R&D) の評価
  • 企業評価クアドラント
  • 競合リーダーシップマッピング:中小企業・スタートアップ向け
  • 競合ベンチマーキング
  • 競合シナリオ
    • 製品の発売と承認
    • 資本取引
    • その他の動向

第11章 企業プロファイル

  • 主要企業
    • BOEHRINGER INGELHEIM GMBH
    • ZOETIS INC.
    • ELANCO ANIMAL HEALTH INCORPORATED
    • MERCK & CO., INC
    • VIRBAC
    • VETOQUINOL S.A.
    • PETIQ, LLC
    • SEQUENT SCIENTIFIC LIMITED
    • KRKA GROUP
    • ECO ANIMAL HEALTH GROUP PLC
  • その他の企業
    • CEVA SANTE ANIMALE
    • CHANELLE PHARMA
    • BIMEDA ANIMAL HEALTH
    • NORBROOK
    • KYORITSU SEIYAKU CORPORATION
    • SMARTVET HOLDINGS, INC.
    • UCBVET
    • CALIER
    • ABBEY ANIMAL HEALTH PTY LTD.
    • BIOGENESIS BAGO
    • PRN PHARMACAL
    • LUTIM PHARMA PRIVATE LIMITED
    • VETANCO SA
    • BRILLIANT BIO PHARMA
    • ZUCHE PHARMACEUTICALS PVT. LTD.

第12章 付録

目次
Product Code: PH 2460

The market for animal parasiticides is anticipated to grow from USD 10.6 billion in 2022 to USD 14.1 billion in 2027, at a CAGR of 5.8% over the forecast period. The market for animal parasiticides is expanding as a result of factors like the rising demand for food products made from animals, growing private player investments, laws aimed at preventing the spread of animal diseases, and rising costs for animal health care. During the projected period, regulations on the use of parasiticides on animals used for food production and a move toward vegetarianism will likely hamper the growth of this market.

"ectoparasiticides segment was dominated by the highest share in animal parasiticides market"

The animal parasiticides market is divided into endoparasiticides, ectoparasiticides, and endectocides based on type. The ectoparasiticides segment accounted for the highest share of the global animal parasiticides market in 2021. The high adoption of ectoparasiticides relative to other products is responsible for the huge proportion of this market. The rise in ownership of animals and the number of companion animals in developed nations are additional factors that are anticipated to promote market expansion throughout the projected period.

"Companion animals segment is accounted for highest market share in the forecast period."

The market for animal parasiticides is divided into divisions for companion animals and livestock animals based on the animal type. The companion animals was the largest segment of the global market for animal parasiticides in 2021. Companion animals accounted for the largest share of the global animal parasiticides market in 2021. The significant market share of this sector is largely due to the rising costs of keeping pets and the rise in the number of people who own companion animals in developed countries.

"Veterinary clinics & hospitals segment is expected to witness the fastest growth in the forecast period."

Animal farms, veterinary clinics & hospitals, and home care settings comprise the end-user segments of the market for animal parasiticides. The fastest growing market for animal parasiticides in 2021 was held by veterinary clinics and hospitals. The increased use of animal parasiticides in medical settings, the rise in parasitic illnesses, and the rising concern over animal health in developing nations are all factors that contribute to the fastest growth of this segment.

"Latin America is expected to witness the fastest growth in the forecast period."

In the forecast period, Latin America in the animal parasiticides market will have the fastest rising regional growth. Rising numbers of companion and food-producing animals, as well as the region's rising demand for food items generated from animals, are the main factors driving market growth. Several countries in Latin America are significant suppliers of beef to the global market. China has been recognized as the primary market for Brazilian beef exports, despite an increase in volume and overall value over the previous year. In the upcoming years, it is anticipated that a rise in beef exports from Latin American nations would support a rise in the market for animal parasiticides in this area.

Following is a list of the major players (supply-side) in the animal parasiticides market that this study refers to:

By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20%

By Designation: C-level- 35%, Director Level-25%, and Others- 40%

By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle

East and Africa-2%

Several of the major companies in the market for animal parasiticides include Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (Ireland).

Research Coverage:

The market study analyzes the main market segments for animal parasiticides. The objective of this study is to estimate the market's size and growth potential across several categories according to kind, animal type, end user, and region. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.

Key Benefits of Buying the Report:

The study provides data regarding the animal parasiticides market's closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market's pulse and learning about its major drivers, inhibitors, opportunities, and problems.

The report provides insights on the following pointers:

Analysis of key drivers (Rising demand for animal-derived food products, Growing prevalence of animal diseases, Regulations for preventing spread of animal diseases), restraints (Regulations restricting use of parasiticides for food-producing animals), opportunities (Lucrative growth opportunities in emerging markets), and challenges (Stringent regulatory approval process for drugs) influencing the growth of the Animal parasiticide market.

Product Development/innovation:

Comprehensive details on new technologies, R&D initiatives, and product and service launches for animal parasiticides market

Market Development:

Comprehensive data on attractive markets, and the research analyzes the global animal parasiticides market.

Market Diversification:

Detailed information on emerging products and services, unexplored regions, current trends, and investments in the animal parasiticide market.

Competitive Assessment:

Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the animal parasiticide market like Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (Ireland).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 ANIMAL PARASITICIDES MARKET SEGMENTATION
    • FIGURE 2 ANIMAL PARASITICIDES MARKET, BY REGION
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
    • 1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 3 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 4 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS INC.
    • FIGURE 10 SUPPLY-SIDE ANALYSIS: ANIMAL PARASITICIDES MARKET (2021)
    • FIGURE 11 COUNTRY-LEVEL ANALYSIS OF ANIMAL PARASITICIDES MARKET
    • FIGURE 12 BOTTOM-UP APPROACH
    • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ANIMAL PARASITICIDES MARKET (2022-2027): IMPACT ON MARKET GROWTH AND CAGR
    • FIGURE 14 CAGR PROJECTIONS
    • FIGURE 15 TOP-DOWN APPROACH
  • 2.3 LIMITATIONS
    • 2.3.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.3.2 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS
  • 2.6 RISK ASSESSMENT/LIMITATIONS
  • 2.7 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY

    • FIGURE 17 ANIMAL PARASITICIDES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 18 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 19 ANIMAL PARASITICIDES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 20 GEOGRAPHICAL SNAPSHOT OF ANIMAL PARASITICIDES MARKET

4 PREMIUM INSIGHTS

  • 4.1 ANIMAL PARASITICIDES MARKET OVERVIEW
    • FIGURE 21 GROWING PREVALENCE OF ANIMAL DISEASES AND RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
  • 4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE AND COUNTRY (2021)
    • FIGURE 22 ECTOPARASITICIDES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ANIMAL PARASITICIDES MARKET IN 2021
  • 4.3 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 ANIMAL PARASITICIDES MARKET: REGIONAL MIX
    • FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE ANIMAL PARASITICIDES MARKET IN 2027
  • 4.5 ANIMAL PARASITICIDES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
    • FIGURE 25 DEVELOPING COUNTRIES TO OFFER GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 26 ANIMAL PARASITICIDES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising demand for animal-derived food products
    • FIGURE 27 WORLD MILK PRODUCTION ESTIMATES (2021-2030)
    • FIGURE 28 WORLD MEAT PRODUCTION ESTIMATES (2021-2030)
      • 5.2.1.2 Increasing investments by private players
      • 5.2.1.3 Growing concerns of zoonotic diseases
      • 5.2.1.4 Regulations for preventing spread of animal diseases
      • 5.2.1.5 Growing companion animal ownership rates
    • FIGURE 29 EUROPE: PET POPULATION
      • 5.2.1.6 Growing prevalence of animal diseases
      • 5.2.1.7 Rising animal health expenditure
    • FIGURE 30 US: INCREASING PET EXPENDITURE, 2010-2021 (USD BILLION)
    • FIGURE 31 EUROPE: ANNUAL VALUE OF PET-RELATED PRODUCTS, 2010-2021 (EUR BILLION)
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Regulations restricting use of parasiticides for food-producing animals
      • 5.2.2.2 Shift toward vegetarianism
      • 5.2.2.3 Novel drug development models
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Lucrative growth opportunities in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Growing resistance to parasiticides
    • TABLE 1 PARASITICIDES AND RESISTANT PARASITES
      • 5.2.4.2 Stringent regulatory approval process for drugs
      • 5.2.4.3 Diversity in parasite species
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE OF ANIMAL PARASITICIDES, BY TYPE
    • TABLE 2 AVERAGE SELLING PRICE OF ANIMAL PARASITICIDES, BY TYPE (USD)
    • 5.3.2 AVERAGE SELLING PRICE TRENDS
  • 5.4 SUPPLY CHAIN ANALYSIS
    • FIGURE 32 SUPPLY CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 33 ECOSYSTEM ANALYSIS: ANIMAL PARASITICIDES MARKET
  • 5.6 PATENT ANALYSIS
    • FIGURE 34 PATENT PUBLICATION TRENDS (JANUARY 2013-FEBRUARY 2023)
    • 5.6.1 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR ANIMAL PARASITICIDES
    • FIGURE 35 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR ANIMAL PARASITICIDE PATENTS (2013-2023)
  • 5.7 VALUE CHAIN ANALYSIS
    • FIGURE 36 VALUE CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET
  • 5.8 CASE STUDIES
    • FIGURE 37 CASE STUDY: MARKET ASSESSMENT FOR COMPANION ANIMALS
    • FIGURE 38 CASE STUDY: OPPORTUNITY ANALYSIS FOR BROAD-SPECTRUM PARASITICIDES
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 REGULATORY LANDSCAPE
    • TABLE 3 US: RECENT DEVELOPMENTS IN REGULATIONS FOR VETERINARY DRUGS
    • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.9.2.1 North America
    • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.9.2.2 Europe
    • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.9.2.3 Asia Pacific and Rest of the World
    • TABLE 6 ASIA PACIFIC AND REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 PORTER'S FIVE FORCES ANALYSIS: ANIMAL PARASITICIDES MARKET (2021)
    • 5.10.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.10.2 BARGAINING POWER OF SUPPLIERS
    • 5.10.3 BARGAINING POWER OF BUYERS
    • 5.10.4 THREAT OF NEW ENTRANTS
    • 5.10.5 THREAT OF SUBSTITUTES
  • 5.11 ADJACENT MARKET ANALYSIS
    • FIGURE 39 ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET: MARKET OVERVIEW
  • 5.12 KEY CONFERENCES AND EVENTS DURING 2023-2024
    • TABLE 8 ANIMAL PARASITICIDES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF ANIMAL PARASITICIDES
    • TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF ANIMAL PARASITICIDES
    • 5.13.2 BUYING CRITERIA
    • TABLE 10 KEY BUYING CRITERIA FOR TOP THREE TYPES OF ANIMAL PARASITICIDES
  • 5.14 TRADE ANALYSIS
  • 5.15 INDUSTRY TRENDS
    • 5.15.1 GROWING CONSOLIDATION IN ANIMAL HEALTH INDUSTRY
    • TABLE 11 MAJOR ACQUISITIONS IN ANIMAL PARASITICIDES INDUSTRY (2019-2021)
    • 5.15.2 INNOVATIONS IN ANIMAL PARASITICIDES
    • TABLE 12 INNOVATIVE ANIMAL PHARMACEUTICAL TRENDS
  • 5.16 IMPACT OF INFLATION AND RECESSION ON ANIMAL PARASITICIDES MARKET

6 ANIMAL PARASITICIDES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 13 ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 14 ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.2 ECTOPARASITICIDES
    • TABLE 15 EXAMPLES OF ECTOPARASITICIDES AVAILABLE IN MARKET
    • TABLE 16 ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 17 ECTOPARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.1 POUR-ONS & SPOT-ONS
      • 6.2.1.1 Ease of application to support adoption
    • TABLE 18 POUR-ONS & SPOT-ONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.2 ORAL TABLETS
      • 6.2.2.1 High medication compliance and ease of administration to drive market
    • TABLE 19 ORAL TABLETS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.3 SPRAYS
      • 6.2.3.1 Low price and convenience to drive market
    • TABLE 20 SPRAYS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.4 DIPS
      • 6.2.4.1 High popularity ensured sustained end-user demand
    • TABLE 21 DIPS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.5 EAR TAGS
      • 6.2.5.1 Highly effective in controlling flies around cattle
    • TABLE 22 EAR TAGS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.6 COLLARS
      • 6.2.6.1 Growing prevalence of infections in companion animals to drive adoption
    • TABLE 23 COLLARS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.7 OTHER ECTOPARASITICIDES
    • TABLE 24 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.3 ENDOPARASITICIDES
    • TABLE 25 EXAMPLES OF ENDOPARASITICIDES AVAILABLE IN MARKET
    • TABLE 26 ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 27 ENDOPARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.1 ORAL LIQUIDS
      • 6.3.1.1 Growing demand for meat and milk products to drive market
    • TABLE 28 ORAL LIQUIDS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.2 ORAL SOLIDS
      • 6.3.2.1 Emergence of internal parasitic infections in dogs to drive market
    • TABLE 29 ORAL SOLIDS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.3 INJECTABLES
      • 6.3.3.1 Mostly used in food-producing animals
    • TABLE 30 INJECTABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.4 FEED ADDITIVES
      • 6.3.4.1 Can be administered to large number of animals at once
    • TABLE 31 FEED ADDITIVES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.5 OTHER ENDOPARASITICIDES
    • TABLE 32 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.4 ENDECTOCIDES
    • 6.4.1 POTENTIAL TO TREAT BOTH INTERNAL AND EXTERNAL PARASITE INFECTIONS
    • TABLE 33 EXAMPLES OF ENDECTOCIDES AVAILABLE IN MARKET
    • TABLE 34 ENDECTOCIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

7 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE

  • 7.1 INTRODUCTION
    • TABLE 35 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
  • 7.2 COMPANION ANIMALS
    • TABLE 36 COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 37 COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.1 DOGS
      • 7.2.1.1 Most adopted companion animals
    • TABLE 38 COMPANION ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.2 CATS
      • 7.2.2.1 High vulnerability to parasitic infections to support market growth
    • TABLE 39 COMPANION ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.3 HORSES
      • 7.2.3.1 Rising need for equine parasitic control to drive market
    • TABLE 40 HORSE POPULATION, BY REGION, 2016-2019 (MILLION)
    • TABLE 41 COMPANION ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.4 OTHER COMPANION ANIMALS
    • TABLE 42 OTHER COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 LIVESTOCK
    • FIGURE 41 PRODUCTION OF MEAT WORLDWIDE, BY TYPE, 2016-2020
    • TABLE 43 LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 44 LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.1 CATTLE
      • 7.3.1.1 Susceptible to parasitic infestations and diseases due to internal parasites
    • TABLE 45 LIVESTOCK PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.2 PIGS
      • 7.3.2.1 Growing pork consumption to drive demand for parasiticides
    • TABLE 46 LIVESTOCK PARASITICIDES MARKET FOR PIGS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.3 POULTRY
      • 7.3.3.1 Growing egg consumption in emerging countries to drive demand for parasiticides
    • FIGURE 42 LEADING EGG-PRODUCING COUNTRIES WORLDWIDE, 2019
    • TABLE 47 LIVESTOCK PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.4 SHEEP & GOATS
      • 7.3.4.1 Growth in consumption of sheep and goat meat to drive market
    • TABLE 48 LIVESTOCK PARASITICIDES MARKET FOR SHEEP & GOATS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.5 OTHER LIVESTOCK
    • TABLE 49 OTHER LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 ANIMAL PARASITICIDES MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 50 ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.2 VETERINARY HOSPITALS AND CLINICS
    • 8.2.1 HIGH ADOPTION OF ANIMAL PARASITICIDES IN VETERINARY HOSPITALS AND CLINICS TO DRIVE MARKET
    • TABLE 51 ANIMAL PARASITICIDES MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 ANIMAL FARMS
    • 8.3.1 INCREASING INCIDENCE OF PARASITIC INFECTIONS IN LIVESTOCK TO SUPPORT MARKET GROWTH
    • TABLE 52 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 HOME CARE SETTINGS
    • 8.4.1 RISING PET OWNERSHIP AND AWARENESS TO DRIVE MARKET
    • TABLE 53 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020-2027 (USD MILLION)

9 ANIMAL PARASITICIDES MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 43 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 54 ANIMAL PARASITICIDES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 44 NORTH AMERICA: ANIMAL PARASITICIDES MARKET SNAPSHOT
    • 9.2.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN NORTH AMERICA
    • TABLE 55 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 56 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 57 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 58 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 59 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 60 NORTH AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 61 NORTH AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 62 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 Rising pet expenditure and increasing meat consumption to drive market
    • FIGURE 45 US: PET ADOPTION DURING COVID-19 PANDEMIC
    • FIGURE 46 US: INCREASE IN PET EXPENDITURE, 2011-2021 (USD BILLION)
    • FIGURE 47 US: BEEF CONSUMPTION, 2011-2021 (BILLION POUNDS)
    • TABLE 63 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2018 VS. 2019 VS. 2020
    • TABLE 64 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 65 US: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 66 US: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 67 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 68 US: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 69 US: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 70 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Growing pet adoption to support market growth
    • TABLE 71 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 72 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 73 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 74 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 75 CANADA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 76 CANADA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 77 CANADA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 78 EUROPE: LIVESTOCK POPULATION, BY TYPE, 2011-2021 (MILLION)
    • 9.3.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN EUROPE
    • TABLE 79 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 80 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 82 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 83 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 84 EUROPE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 85 EUROPE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Growing demand for quality animal-derived food products to drive market
    • TABLE 87 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 88 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 89 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 90 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 91 GERMANY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 92 GERMANY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Increasing pet ownership to drive market
    • TABLE 94 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 95 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 96 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 98 UK: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 UK: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 100 UK: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.4 FRANCE
      • 9.3.4.1 Presence of major market players to propel market growth
    • TABLE 101 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 102 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 105 FRANCE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 106 FRANCE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 107 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing animal health expenditure to drive market
    • TABLE 108 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 109 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 110 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 112 SPAIN: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 SPAIN: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 114 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.6 ITALY
      • 9.3.6.1 Need to curb zoonotic diseases in livestock to propel market
    • TABLE 115 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 116 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 117 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 119 ITALY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 ITALY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 121 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • FIGURE 48 NETHERLANDS: NUMBER OF DAIRY COWS, 2011-2020 (THOUSAND)
    • TABLE 122 REST OF EUROPE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2021 (MILLION)
    • TABLE 123 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 124 REST OF EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 125 REST OF EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 127 REST OF EUROPE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 128 REST OF EUROPE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 129 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 49 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET SNAPSHOT
    • 9.4.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN ASIA PACIFIC
    • TABLE 130 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 131 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Increasing pet expenditure and companion animal ownership to propel market
    • FIGURE 50 CHINA: CONSUMPTION OF PORK PRODUCTS PER CAPITA, 2011-2021 (KILOGRAMS)
    • TABLE 138 CHINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 139 CHINA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 140 CHINA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 141 CHINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 142 CHINA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 143 CHINA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 144 CHINA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.3 AUSTRALIA & NEW ZEALAND
      • 9.4.3.1 Rising livestock population and increasing awareness about parasitic infections to drive market
    • TABLE 145 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 AUSTRALIA & NEW ZEALAND: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 147 AUSTRALIA & NEW ZEALAND: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 148 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 149 AUSTRALIA & NEW ZEALAND: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 150 AUSTRALIA & NEW ZEALAND: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 151 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.4 JAPAN
      • 9.4.4.1 Rising pet care expenditure to propel market
    • TABLE 152 JAPAN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 JAPAN: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 154 JAPAN: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 155 JAPAN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 156 JAPAN: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 157 JAPAN: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 158 JAPAN: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.5 INDIA
      • 9.4.5.1 Rising demand for animal-derived food products to support market growth
    • TABLE 159 INDIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 160 INDIA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 161 INDIA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 162 INDIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 163 INDIA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 164 INDIA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 165 INDIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Rising investments in animal healthcare infrastructure to propel market
    • TABLE 166 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 167 SOUTH KOREA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 168 SOUTH KOREA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 169 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 170 SOUTH KOREA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 SOUTH KOREA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.7 REST OF ASIA PACIFIC
    • TABLE 173 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 174 REST OF ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 175 REST OF ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 176 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 177 REST OF ASIA PACIFIC: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 178 REST OF ASIA PACIFIC: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN LATIN AMERICA
    • TABLE 180 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 181 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 182 LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 183 LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 184 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 185 LATIN AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 186 LATIN AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 187 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.5.2 BRAZIL
      • 9.5.2.1 Growing prevalence of zoonotic diseases to drive market
    • TABLE 188 BRAZIL: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 189 BRAZIL: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 190 BRAZIL: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 191 BRAZIL: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 192 BRAZIL: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 193 BRAZIL: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 194 BRAZIL: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.5.3 REST OF LATIN AMERICA
    • TABLE 195 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 196 REST OF LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 197 REST OF LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 198 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 199 REST OF LATIN AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 200 REST OF LATIN AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 201 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN MIDDLE EAST AND AFRICA
    • TABLE 202 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 203 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 204 MIDDLE EAST AND AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 205 MIDDLE EAST AND AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 206 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 207 MIDDLE EAST AND AFRICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 208 MIDDLE EAST AND AFRICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 209 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.6.2 TURKEY
      • 9.6.2.1 Increase in companion animal population to drive market
    • TABLE 210 TURKEY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 211 TURKEY: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 212 TURKEY: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 213 TURKEY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 214 TURKEY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 215 TURKEY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 216 TURKEY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.6.3 REST OF MIDDLE EAST AND AFRICA
    • TABLE 217 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 218 REST OF MIDDLE EAST AND AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 219 REST OF MIDDLE EAST AND AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 220 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 221 REST OF MIDDLE EAST AND AFRICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 222 REST OF MIDDLE EAST AND AFRICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION)
    • TABLE 223 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES
    • FIGURE 51 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN ANIMAL PARASITICIDES MARKET
  • 10.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN ANIMAL PARASITICIDES MARKET
    • FIGURE 52 REVENUE ANALYSIS FOR KEY PLAYERS IN ANIMAL PARASITICIDES MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 53 ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
    • TABLE 224 ANIMAL PARASITICIDES MARKET: DEGREE OF COMPETITION
  • 10.5 R&D ASSESSMENT OF KEY PLAYERS
  • 10.6 COMPANY EVALUATION QUADRANT
    • FIGURE 54 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX, 2021
    • 10.6.1 STARS
    • 10.6.2 PERVASIVE PLAYERS
    • 10.6.3 EMERGING LEADERS
    • 10.6.4 PARTICIPANTS
  • 10.7 COMPETITIVE LEADERSHIP MAPPING FOR SMES AND STARTUPS
    • FIGURE 55 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX FOR SMES AND STARTUPS, 2021
    • 10.7.1 PROGRESSIVE COMPANIES
    • 10.7.2 DYNAMIC COMPANIES
    • 10.7.3 STARTING BLOCKS
    • 10.7.4 RESPONSIVE COMPANIES
  • 10.8 COMPETITIVE BENCHMARKING
    • 10.8.1 OVERALL COMPANY FOOTPRINT
    • TABLE 225 OVERALL COMPANY FOOTPRINT
    • TABLE 226 COMPANY FOOTPRINT ANALYSIS, BY TYPE
    • TABLE 227 COMPANY FOOTPRINT ANALYSIS, BY ANIMAL TYPE
    • TABLE 228 COMPANY FOOTPRINT ANALYSIS, BY END USER
    • TABLE 229 COMPANY FOOTPRINT ANALYSIS, BY REGION
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
    • TABLE 230 PRODUCT LAUNCHES AND APPROVALS, JANUARY 2019-FEBRUARY 2023
    • 10.9.2 DEALS
    • TABLE 231 DEALS, JANUARY 2019-FEBRUARY 2023
    • 10.9.3 OTHER DEVELOPMENTS
    • TABLE 232 OTHER DEVELOPMENTS, JANUARY 2019-FEBRUARY 2023

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

    • 11.1.1 BOEHRINGER INGELHEIM GMBH
    • TABLE 233 BOEHRINGER INGELHEIM GMBH: BUSINESS OVERVIEW
    • FIGURE 56 BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT (2021)
    • 11.1.2 ZOETIS INC.
    • TABLE 234 ZOETIS INC.: BUSINESS OVERVIEW
    • FIGURE 57 ZOETIS INC.: COMPANY SNAPSHOT (2021)
    • 11.1.3 ELANCO ANIMAL HEALTH INCORPORATED
    • TABLE 235 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 58 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2021)
    • 11.1.4 MERCK & CO., INC
    • TABLE 236 MERCK & CO., INC.: BUSINESS OVERVIEW
    • FIGURE 59 MERCK & CO., INC.: COMPANY SNAPSHOT (2021)
    • 11.1.5 VIRBAC
    • TABLE 237 VIRBAC: BUSINESS OVERVIEW
    • FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2021)
    • 11.1.6 VETOQUINOL S.A.
    • TABLE 238 VETOQUINOL S.A.: BUSINESS OVERVIEW
    • FIGURE 61 VETOQUINOL S.A.: COMPANY SNAPSHOT (2021)
    • 11.1.7 PETIQ, LLC
    • TABLE 239 PETIQ, LLC: BUSINESS OVERVIEW
    • FIGURE 62 PETIQ, LLC: COMPANY SNAPSHOT (2021)
    • 11.1.8 SEQUENT SCIENTIFIC LIMITED
    • TABLE 240 SEQUENT SCIENTIFIC LIMITED: BUSINESS OVERVIEW
    • FIGURE 63 SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT (2021)
    • 11.1.9 KRKA GROUP
    • TABLE 241 KRKA GROUP: BUSINESS OVERVIEW
    • FIGURE 64 KRKA GROUP: COMPANY SNAPSHOT (2021)
    • 11.1.10 ECO ANIMAL HEALTH GROUP PLC
    • TABLE 242 ECO ANIMAL HEALTH GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 65 ECO ANIMAL HEALTH GROUP PLC: COMPANY SNAPSHOT (2021)
  • 11.2 OTHER PLAYERS
    • 11.2.1 CEVA SANTE ANIMALE
    • TABLE 243 CEVA SANTE ANIMALE: BUSINESS OVERVIEW
    • 11.2.2 CHANELLE PHARMA
    • TABLE 244 CHANELLE PHARMA: BUSINESS OVERVIEW
    • 11.2.3 BIMEDA ANIMAL HEALTH
    • TABLE 245 BIMEDA ANIMAL HEALTH: BUSINESS OVERVIEW
    • 11.2.4 NORBROOK
    • TABLE 246 NORBROOK: BUSINESS OVERVIEW
    • 11.2.5 KYORITSU SEIYAKU CORPORATION
    • TABLE 247 KYORITSU SEIYAKU CORPORATION: BUSINESS OVERVIEW
    • 11.2.6 SMARTVET HOLDINGS, INC.
    • TABLE 248 SMARTVET HOLDINGS, INC.: BUSINESS OVERVIEW
    • 11.2.7 UCBVET
    • TABLE 249 UCBVET: BUSINESS OVERVIEW
    • 11.2.8 CALIER
    • TABLE 250 CALIER: BUSINESS OVERVIEW
    • 11.2.9 ABBEY ANIMAL HEALTH PTY LTD.
    • TABLE 251 ABBEY ANIMAL HEALTH PTY LTD.: BUSINESS OVERVIEW
    • 11.2.10 BIOGENESIS BAGO
    • TABLE 252 BIOGENESIS BAGO: BUSINESS OVERVIEW
    • 11.2.11 PRN PHARMACAL
    • TABLE 253 PRN PHARMACAL: BUSINESS OVERVIEW
    • 11.2.12 LUTIM PHARMA PRIVATE LIMITED
    • TABLE 254 LUTIM PHARMA PRIVATE LIMITED: BUSINESS OVERVIEW
    • 11.2.13 VETANCO SA
    • TABLE 255 VETANCO SA: BUSINESS OVERVIEW
    • 11.2.14 BRILLIANT BIO PHARMA
    • TABLE 256 BRILLIANT BIO PHARMA: BUSINESS OVERVIEW
    • 11.2.15 ZUCHE PHARMACEUTICALS PVT. LTD.
    • TABLE 257 ZUCHE PHARMACEUTICALS PVT. LTD.: BUSINESS OVERVIEW
  • Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS